FR2872044B1 - Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire - Google Patents

Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire

Info

Publication number
FR2872044B1
FR2872044B1 FR0451353A FR0451353A FR2872044B1 FR 2872044 B1 FR2872044 B1 FR 2872044B1 FR 0451353 A FR0451353 A FR 0451353A FR 0451353 A FR0451353 A FR 0451353A FR 2872044 B1 FR2872044 B1 FR 2872044B1
Authority
FR
France
Prior art keywords
antibiotics
pharmaceutical formulation
formulation based
microcapsular form
microcapsular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0451353A
Other languages
English (en)
Other versions
FR2872044A1 (fr
Inventor
Florence Guimberteau
Catherine Castan
Remi Meyrueix
Gerard Soula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0451353A priority Critical patent/FR2872044B1/fr
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Priority to US11/631,030 priority patent/US20080026056A1/en
Priority to CA002571045A priority patent/CA2571045A1/fr
Priority to JP2007518654A priority patent/JP2008504352A/ja
Priority to EP05766691A priority patent/EP1776113A1/fr
Priority to CNA2005800214391A priority patent/CN101014340A/zh
Priority to PCT/FR2005/050366 priority patent/WO2006010868A1/fr
Priority to TW094117656A priority patent/TW200602090A/zh
Publication of FR2872044A1 publication Critical patent/FR2872044A1/fr
Application granted granted Critical
Publication of FR2872044B1 publication Critical patent/FR2872044B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0451353A 2004-06-28 2004-06-28 Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire Expired - Fee Related FR2872044B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0451353A FR2872044B1 (fr) 2004-06-28 2004-06-28 Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
CA002571045A CA2571045A1 (fr) 2004-06-28 2005-05-25 Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
JP2007518654A JP2008504352A (ja) 2004-06-28 2005-05-25 マイクロカプセル形態の抗生物質を主成分とする製剤処方
EP05766691A EP1776113A1 (fr) 2004-06-28 2005-05-25 Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
US11/631,030 US20080026056A1 (en) 2004-06-28 2005-05-25 Antibiotic-Based Pharmaceutical Formulation in Microcapsular Form
CNA2005800214391A CN101014340A (zh) 2004-06-28 2005-05-25 微囊形式的基于抗生素的药物制剂
PCT/FR2005/050366 WO2006010868A1 (fr) 2004-06-28 2005-05-25 Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
TW094117656A TW200602090A (en) 2004-06-28 2005-05-30 Antibiotic-based pharmaceutical formulation in microcapsular form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0451353A FR2872044B1 (fr) 2004-06-28 2004-06-28 Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire

Publications (2)

Publication Number Publication Date
FR2872044A1 FR2872044A1 (fr) 2005-12-30
FR2872044B1 true FR2872044B1 (fr) 2007-06-29

Family

ID=34948853

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0451353A Expired - Fee Related FR2872044B1 (fr) 2004-06-28 2004-06-28 Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire

Country Status (8)

Country Link
US (1) US20080026056A1 (fr)
EP (1) EP1776113A1 (fr)
JP (1) JP2008504352A (fr)
CN (1) CN101014340A (fr)
CA (1) CA2571045A1 (fr)
FR (1) FR2872044B1 (fr)
TW (1) TW200602090A (fr)
WO (1) WO2006010868A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
FR2901478B1 (fr) * 2006-05-24 2015-06-05 Flamel Tech Sa Forme pharmaceutique orale multimicroparticulaire a liberation prolongee
EP2266581B1 (fr) * 2008-03-18 2015-09-23 Dikovskiy, Aleksander Vladimirovich Composition pharmaceutique à base d'antibiotiques et de prébiotiques destinée au traitement de dysbioses dans un processus de thérapie antibactérienne
WO2010089767A1 (fr) * 2009-01-09 2010-08-12 Panacea Biotec Ltd. Suspension pharmaceutique à double libération
CN101890007B (zh) * 2010-08-04 2012-05-23 胡建荣 一种阿莫西林钠克拉维酸钾药物组合物微球注射剂
MX346244B (es) * 2011-05-19 2017-03-13 Savara Inc Composiciones de vancomicina en polvo seco y metodos asociados.
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
WO2013173808A2 (fr) * 2012-05-17 2013-11-21 Michael Spector Procédés d'utilisation de compositions à dose plus faible d'amoxicilline et de clavulanate de potassium et dispositifs d'utilisation
CN109715156A (zh) 2016-07-14 2019-05-03 尔察祯有限公司 用于治疗细菌感染的头孢布烯和克拉维酸的组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
EP1353651A2 (fr) * 2001-01-18 2003-10-22 Natco Pharma Limited Compositions pharmaceutiques a liberation lente contenant des antibiotiques beta-lactame
IL164221A0 (en) * 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim

Also Published As

Publication number Publication date
WO2006010868A1 (fr) 2006-02-02
US20080026056A1 (en) 2008-01-31
CA2571045A1 (fr) 2006-02-02
JP2008504352A (ja) 2008-02-14
EP1776113A1 (fr) 2007-04-25
TW200602090A (en) 2006-01-16
FR2872044A1 (fr) 2005-12-30
CN101014340A (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
DE602004025950D1 (de) Pharmazeutische formulierung mit lanthanum-verbindungen
HK1078851A1 (en) 2-Indolinone-monoethanesulphonate and the use thereof in preparing a pharmaceutical composition
NO20033384D0 (no) Farmasöytisk formulering
DE60213592D1 (de) Flüssige pharmazeutische zusammensetzung
IL221199A (en) A fragrance-containing drug
NO20033785D0 (no) Farmasöytisk formulering
DK1633388T3 (da) Flydende stabiliserede interferon-beta-formuleringer i coatede farmaceutiske beholdere
DE60111769D1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
NO20035627D0 (no) Farmasöytisk formulering
FR2872044B1 (fr) Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
HUP0303948A2 (hu) Szájban diszpergálódó szilárd gyógyszerforma
DE60305728D1 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
IT1313579B1 (it) Composizione farmaceutica liquida a base di paracetamolo.
ATE290366T1 (de) Pharmazeutische formulierung mit überdecktem geschmack und verfahren zu ihrer herstellung
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
HK1086819A1 (en) 2-(butyl-1-sulfonylamino)-n-(1(r)-(6-methoxy-pyridin-3-yl)-propyl)-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
AR025867A1 (es) Formulacion portasdora farmaceutica
DE10291905D2 (de) Pharmazeutische Zusammensetzung
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
IL182124A0 (en) Pharmaceutical compositions containing (-)-(s)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane and salts thereof
NO20004816D0 (no) Ny farmasøytisk formulering

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090228